<

According to the introduction of sodium heparin?

  Heparin sodium API supplier introduction: enoxaparin sodium alias: xay, enoxaparin sodium; Foreign languages: enoxaparin, LMW- Hydrogen, Celixen

  1. Efficacy: enoxapparin can effectively prevent thrombosis and pulmonary embolism, effectively treat venous thrombosis, prevent thrombosis in the process of extracorporeal hemodialysis, and treat unstable angina pectoris and non-Q wave myocardial infarction.

  2. Dose and Usage: To prevent DVT, adults at high risk of thrombosis were given 40mg 12 hours before surgery, and then subcutaneously injected 40mg every 24 hours. Patients at moderate risk of thrombus were given 20mg 2 hours before surgery and subcutaneously every 24 hours. These treatments should be continued for 10-14 days or until the risk of thrombosis disappears. The venous thrombosis formed was treated with 1 mg/kg body weight subcutaneously every 12 hours for 10 days. A single dose of 1mg/kg body weight was given before cardiopulmonary bypass dialysis. These doses are sufficient for 4 h of dialysis therapy (unless fibrin rings form). If prolonged dialysis is required, a quarter of the above dose should be added every hour. Unstable angina pectoris and non-Q-wave myocardial infarction were injected subcutaneously every 12 hours within 24 hours and continued for 6-8 days until clinical symptoms were stable.

According to the introduction of sodium heparin?

  3, contraindication: acute bacterial endocarditis, massive hemorrhage, thrombocytopenia; Active digestive information system ulcer, stroke (except due to the risk of systemic embolism) and bleeding management tendency.

  4, adverse reactions: can lead to thrombocytopenia and abnormal liver function.

  Heparin Sodium API Supplier reminds everyone that this medication should not be used for intramuscular injection. Use with caution for liver dysfunction, uncontrolled arterial hypertension, gastrointestinal ulcers and pregnant women. Pregnant women should weigh the pros and cons of using this drug.